164 related articles for article (PubMed ID: 21346683)
1. Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
van Damme P; Kafeja F; Van Der Wielen M; Leyssen M; Jacquet JM
Pediatr Infect Dis J; 2011 Aug; 30(8):703-5. PubMed ID: 21346683
[TBL] [Abstract][Full Text] [Related]
2. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
Marshall H; Nolan T; Díez Domingo J; Rombo L; Sokal EM; Marès J; Casanovas JM; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Jun; 28(27):4411-5. PubMed ID: 20434544
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Crasta P; Messier M; Jacquet JM; Van Herck K
J Med Virol; 2012 Jan; 84(1):11-7. PubMed ID: 22052690
[TBL] [Abstract][Full Text] [Related]
4. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
7. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
8. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.
Höhler T; Groeger-Bicanic G; Hoet B; Stoffel M
Vaccine; 2007 Feb; 25(8):1503-8. PubMed ID: 17097774
[TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
11. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
13. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
Chlibek R; Smetana J; Bostíková V; Splino M
Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
[TBL] [Abstract][Full Text] [Related]
14. Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents.
Diaz-Mitoma F; Law B; Subramanya A; Hoet B
Vaccine; 2008 Mar; 26(14):1759-63. PubMed ID: 18336963
[TBL] [Abstract][Full Text] [Related]
15. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
Beran J; Van Der Meeren O; Leyssen M; D'silva P
Vaccine; 2016 May; 34(24):2686-91. PubMed ID: 27105563
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immune responses to combined hepatitis A and B vaccine in HIV-infected children and children on immunosuppressive medication.
Belderok SM; Sonder GJ; van Rossum M; van Dijk-Hummelman A; Hartwig N; Scherpbier H; Geelen S; Speksnijder AG; Baaten G; van den Hoek A
Vaccine; 2013 Aug; 31(38):4156-63. PubMed ID: 23845818
[TBL] [Abstract][Full Text] [Related]
17. The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.
Chen Y; Gu H; Cheng S; Shen L; Cui F; Wang F; Yao J; Xia S; Lv H; Liang X
Hum Vaccin Immunother; 2013 Apr; 9(4):898-902. PubMed ID: 23295964
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
19. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
Van Herck K; Jacquet JM; Van Damme P
J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]